Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
307
Zitationen
8
Autoren
2016
Jahr
Abstract
MTV-0 is an important prognostic factor in DLBCL. Combining MTV-0 and early PET/CT response improves the predictive power of interim PET and defines a poor-prognosis group in whom most of the events occur.
Ähnliche Arbeiten
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
2012 · 18.365 Zit.
Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
1997 · 11.421 Zit.
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
2000 · 9.919 Zit.
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
1977 · 8.398 Zit.
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 · 7.754 Zit.